Skip to content

Clinical trials

Completed Phase 1/2 Carcinoma, Medullary trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Medullary Phase: Phase 1/2 Status: Completed Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20121
20131
20171

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Garden State Cancer Center at the Center for Molecular Medicine and Immunology1
Genzyme, a Sanofi Company1
Hoffmann-La Roche1
Nantes University Hospital1
National Cancer Institute (NCI)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Medullary5
Head and Neck Neoplasms2
Multiple Endocrine Neoplasia Type 2a2
Thyroid Diseases2
Adenocarcinoma1
Adenocarcinoma, Papillary1
Bronchial Neoplasms1
Carcinoma1
Carcinoma, Bronchogenic1
Carcinoma, Neuroendocrine1

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.